Henry L Gomez

13PUBLICATIONS
148CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Aboriginal and Torres Strait Islander midwifery and paediatrics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 19, 2026
Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trial.

|Nov 07, 2024
Impact on Survival with Immunotherapy and Evaluation of Biomarkers in Peruvian Patients with Advanced Melanoma.

Guillermo Valencia, Katia Roque, Patricia Rioja

|Apr 30, 2024
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer.

Elizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson

|Mar 11, 2024
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy.

Miguel Martín, Rachel Yoder, Roberto Salgado

|Oct 04, 2023
NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer.

Brandie C Taylor, Xiaopeng Sun, Paula I Gonzalez-Ericsson

|Nov 08, 2022
Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine.

Karama Asleh, Ana Lluch, Angela Goytain

Pageof 3

Frequent Collaborators

3 joint publications

Hugo Fuentes

3 joint publications

Paula I Gonzalez-Ericsson

3 joint publications

Justin M Balko

3 joint publications

Lajos Pusztai